Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the -ligands
- 15 February 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (7) , 1869-1873
- https://doi.org/10.1016/j.bmcl.2006.01.011
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Structure-Based Design: Synthesis and Biological Evaluation of a Series of Novel Cycloamide-Derived HIV-1 Protease InhibitorsJournal of Medicinal Chemistry, 2005
- High Resolution Crystal Structures of HIV-1 Protease with a Potent Non-peptide Inhibitor (UIC-94017) Active Against Multi-drug-resistant Clinical StrainsJournal of Molecular Biology, 2004
- Countering Cooperative Effects in Protease Inhibitors Using Constrained β-Strand-Mimicking Templates in Focused Combinatorial LibrariesJournal of Medicinal Chemistry, 2004
- β-Strand Mimicking Macrocyclic Amino Acids: Templates for Protease Inhibitors with Antiviral ActivityJournal of Medicinal Chemistry, 2001
- Structure-based design of non-peptide HIV protease inhibitorsIl Farmaco, 2001
- Structure-activity relationships for macrocyclic peptidomimetic inhibitors of HIV-1 proteaseBioorganic & Medicinal Chemistry Letters, 1996
- A Novel Bicyclic Enzyme Inhibitor as a Consensus Peptidomimetic for the Receptor-Bound Conformations of 12 Peptidic Inhibitors of HIV-1 ProteaseJournal of the American Chemical Society, 1996
- Structure-Based Design of HIV-1 Protease Inhibitors: Replacement of Two Amides and a 10.pi.-Aromatic System by a Fused Bis-tetrahydrofuranJournal of Medicinal Chemistry, 1994
- Rational Design of Peptide-Based HIV Proteinase InhibitorsScience, 1990
- 4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone: a prejunctional dopamine receptor agonistJournal of Medicinal Chemistry, 1985